Message from a MCCR Board Member

It is unfortunately common to hear that someone we know, whether it be a spouse, family member, friend, colleague, or neighbor, has received a cancer diagnosis. We are aware of the usual methods of treatment, such as chemotherapy, surgery and radiation, each of which has its benefits, but also invasive and tiring.

However, serving on the board of Mary Crowley Cancer Research (MCCR), I have gained knowledge that I believe every cancer patient should be aware of. There have been incredible advancements in early genomic testing and clinical trials over the past decade, and I want to share this information with you.

I must mention that I have no specialized or professional medical knowledge, and therefore, I encourage you to consult with your personal doctor or oncologist regarding the information I provide.

Genomic testing seeks gene mutations in your cancer, which can lead to alternative treatment options such as clinical trials. These trials can be less invasive and toxic, and may be appropriate for your specific situation. It’s important to note that not every patient is eligible for a clinical trial, but what if there is one that could benefit you? Wouldn’t you want to know?

Unlike in the past, clinical trials today are not based on placebos, but rather targeted treatments for specific types of cancer. The MCCR staff is up-to-date on the many ongoing or proposed clinical trials. After reviewing your genomic test results, they can search for trials that might be suitable for you and present their recommendations to your oncologist.

Just like with surgery, patients must be healthy enough to participate in clinical trials. Therefore, it’s best to complete your genomic testing early to give you the most treatment options.

Mary Crowley Cancer Research has been conducting clinical trials for patients in the DFW area for 26 years. Their staff is known for their excellent care and reputation.

HOPE LIVES HERE!